Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prophylactic surgery in hereditary breast/ovarian cancer syndrome.

Oncology (Williston Park, N.Y.) - 1 Jul 2003

Levine Douglas A, Gemignani Mary L

Abstract excerpt

The hereditary breast/ovarian cancer syndrome is responsible for approximately 5% of all breast cancers and 10% of all ovarian cancers. Although this accounts for a small portion of these diseases, much attention has been focused on this syndrome because of the abundance of research in this area. The majority of the hereditary breast/ovarian syndrome can be attributed to germ-line mutations in the BRCA1 and BRCA2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mastectomy
Share to Genes, BRCA2
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Neoplastic Syndromes, Hereditary

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Tamoxifen

Source

Identifiers

PMID: 12886864

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prophylactic surgery in hereditary breast/ovarian cancer syndrome.PMID 12886864Read ↗

Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.Semantic proximity Read ↗

Current status of prophylactic surgery for hereditary breast and gynecologic cancers.Semantic proximity Read ↗

Risk-reducing surgery on the uterine adnexa: timing and type of surgical treatment, and pathology report.Semantic proximity Read ↗

Management options after prophylactic surgeries in women with BRCA mutations: a review.Semantic proximity Read ↗

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Semantic proximity Read ↗

Prophylactic breast surgery for women with BRCA1 and BRCA2 germline mutations.Semantic proximity Read ↗

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.Semantic proximity Read ↗

Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.Semantic proximity Read ↗

BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.Semantic proximity Read ↗

Hereditary Women's Cancer: Management and Risk-Reducing Surgery.Semantic proximity Read ↗

Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.